Community-acquired pneumonia - Optimizing antibiotic usage

Current Opinion in Pulmonary Medicine

Volumn 10, Issue SUPPL. 1, 2004, Pages

  Schwartz, Douglas B ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE;

ADULT; ANTIBIOTIC THERAPY; CLINICAL FEATURE; COMMUNICABLE DISEASE; CONFERENCE PAPER; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MALE; MYCOPLASMA PNEUMONIAE; PATIENT SELECTION; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 7244250101     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000143178.45999.73     Document Type: Conference Paper

References (18)

1. Niederman MS, McCombs JS, Linger AN, et al.: The cost of treating community-acquired pneumonia. Clin Ther 1998, 20:820-837.
2. Marston BJ, Ploutfe JF, File TM Jr, et al.: Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997, 157:1709-1718.
3. Marrie TJ, Peeling RW, Fine MJ, et al.: Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996, 101:508-515.
4. Fang GD, Fine M, Orloff J, et al.: New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990, 69:307-316.
5. Kauppinen MT, Saikku P, Kujala P, et al.: Clinical picture of community-acquired Chlamydia pneumonias pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996, 51:185-189.
6. Fine MJ, Auble TE, Yealy DM, et al.: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
7. Atlas SJ, Benzer TI, Borowsky LH, et al.: Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 1998, 158:1350-1356.
8. Niederman MS, Mandell LA, Anzueto A, et al.: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754.
9. Rhew DC, Hackner D, Henderson L, et al.: The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest 1998, 113:142-146.
10. Rothermel CD: Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale. Curr Ther Res. 2003, 64(suppl A):A4-A15.
11. Rodvold KA, Danziger LH, Gotfried MH: Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrob Agents Chemother 2003, 47:2450-2457.
12. Meehan TP, Fine MJ, Krumholz HM, et al.: Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997, 278:2080-2084.
13. Battleman DS, Callahan M, Thaler HT: Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002, 162:682-688.
14. Stahl JE, Barza M, DesJardin J, et al.: Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999, 159:2576-2580.
15. Law C, Amsden GW: Single-dose azithromycin for respiratory tract infections. Ann Pharmacother 2004, 38:433-439.
16. Siegel RE, Halpern NA, Almenoff PL, et al.: A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest 1996, 110:965-971.
17. Kardas P: Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 2002, 49:897-903.
18. Perez-Gorricho B, Ripoll M: Does short-course antibiotic therapy better meet patient expectations? Int J Antimicrob Agents 2003, 21:222-228.